Eli Lilly in Advanced Talks for $2 Billion Kelonia Therapeutics Acquisition
Prime Highlights Eli Lilly is in advanced discussions to acquire Kelonia Therapeutics in a deal valued at more than $2 billion, according to media reports. The potential acquisition is expected…